Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in the Netherlands.
79

Chapter 7
Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination.
Mirte Scherpenisse, Madelief Mollers, Rutger M. Schepp, Chris J. L. M. Meijer, Hester E. de Melker, Guy A. M. Berbers, Fiona R. M. van der Klis. Published in Human Vaccines & Immunotherapeutics, 2012, Vol. 9, No. 2: 1-8, 314-321 .
Chapter 8
Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: A prospective controlled observational cohort study. Diseases, 2013 Diseases, , doi:10.1136 Diseases, /annrheumdis-2013 .
Chapter 9
Immunogenicity of the bivalent HPV vaccine in adolescents with juvenile systemic lupus erythematosus, juvenile dermatomyositis or overlap syndromes. 
